News - Appointments

MorphoSys names Markus Enzelberger as CSO

Markus Enzelberger

MorphoSys AG has named Markus Enzelberger as chief scientific officer. He has served as interim CSO since April.

Country: Germany

Read more

Edward Kim to chair Inivata scientific advisory board

Edward Kim

Edward Kim of the Levine Cancer Institute in North Carolina, US has been appointed chair of a new scientific advisory board at Inivata Ltd, a UK company developing a liquid biopsy test for cancer.

Country: United Kingdom

Read more

Sébastien Desprez becomes head of IR at Adaptimmune

Sébastien Desprez

Sébastien Desprez has joined Adaptimmune Therapeutics Plc from ViiV Healthcare to direct communications and investor relations.

Country: United Kingdom

Read more

Jan van de Winkel becomes chair of Hookipa Biotech

Jan van de Winkel

The Austria-based biotech company Hookipa Biotech AG has appointed Jan van de Winkel as chairman of its board of directors to help oversee the progress of its early-stage vaccine portfolio.

Country: Austria

Read more

Annalisa Jenkins joins Silence Therapeutics as non-executive chair

Annalisa Jenkins

Silence Therapeutics Plc, which is developing RNA-based therapeutics, has appointed Annalisa Jenkins as non-executive chair of its board of directors.

Country: United Kingdom

Read more

Cliff Holloway appointed CEO of Scancell

Cliff Holloway

Cliff Holloway is to join Scancell Holdings Plc as chief executive on 10 January 2018, succeeding Richard Goodfellow who will remain on the company’s board of directors.

Country: United Kingdom

Read more

Norbert Oppitz to head specialty care at Sobi

Norbert Oppitz

Norbert Oppitz, a veteran pharmaceutical executive, has joined Swedish Orphan Biovitrum AB to head its newly established business unit for specialty care pharmaceuticals.

Country: Sweden

Read more

Andrew Hotchkiss becomes CCO at Immunocore

Andrew Hotchkiss

Immunocore Ltd, which is developing cancer therapies based on T cell receptors, has appointed Andrew Hotchkiss as its chief commercial officer.

Country: United Kingdom

Read more

Jeffrey Luber becomes CEO at Atlas Genetics

Jeffrey Luber

Atlas Genetics Ltd of the UK has appointed Jeffrey Luber as its chief executive, succeeding the founding CEO John Clarkson, who has become executive chairman.

Country: United Kingdom

Read more

Sanofi promotes Stefan Oelrich

Stefan Oelrich

Sanofi SA has promoted its diabetes executive Stefan Oelrich to the position of vice president for the diabetes and cardiovascular business unit with a seat on the company’s executive committ

Country: France

Read more